Innophos Holdings, Inc. (NASDAQ:IPHS) Rating Increased to Strong-Buy at Zacks Investment Research
Innophos Holdings, Inc. (NASDAQ:IPHS) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued on Tuesday. The brokerage presently has a $54.00 price objective on the specialty chemicals company’s stock. Zacks Investment Research‘s target price indicates a potential upside of 15.48% from the company’s previous close.
According to Zacks, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation. “
A number of other equities research analysts also recently weighed in on IPHS. Sidoti upgraded Innophos Holdings from a “neutral” rating to a “buy” rating in a report on Friday, May 26th. They noted that the move was a valuation call. BidaskClub downgraded Innophos Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th.
Shares of Innophos Holdings (IPHS) traded down 1.16% on Tuesday, hitting $46.76. 87,522 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $43.77 and its 200 day moving average price is $47.21. Innophos Holdings has a 1-year low of $37.02 and a 1-year high of $58.22. The company has a market cap of $906.96 million, a price-to-earnings ratio of 20.42 and a beta of 0.85.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. The company had revenue of $179.14 million during the quarter, compared to the consensus estimate of $172.65 million. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. The firm’s revenue was down 1.5% compared to the same quarter last year. During the same period last year, the company earned $0.63 earnings per share. On average, equities research analysts expect that Innophos Holdings will post $2.51 earnings per share for the current year.
WARNING: This piece of content was reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/08/innophos-holdings-inc-nasdaqiphs-rating-increased-to-strong-buy-at-zacks-investment-research.html.
A number of large investors have recently modified their holdings of IPHS. Teachers Advisors LLC increased its stake in shares of Innophos Holdings by 23.9% in the fourth quarter. Teachers Advisors LLC now owns 53,259 shares of the specialty chemicals company’s stock worth $2,783,000 after buying an additional 10,266 shares during the last quarter. Americafirst Capital Management LLC acquired a new stake in shares of Innophos Holdings during the first quarter worth $528,000. Louisiana State Employees Retirement System increased its stake in shares of Innophos Holdings by 1.3% in the first quarter. Louisiana State Employees Retirement System now owns 7,900 shares of the specialty chemicals company’s stock worth $426,000 after buying an additional 100 shares during the last quarter. State of Alaska Department of Revenue increased its stake in shares of Innophos Holdings by 81.4% in the first quarter. State of Alaska Department of Revenue now owns 3,810 shares of the specialty chemicals company’s stock worth $205,000 after buying an additional 1,710 shares during the last quarter. Finally, Personal Capital Advisors Corp increased its stake in shares of Innophos Holdings by 9.6% in the first quarter. Personal Capital Advisors Corp now owns 110,646 shares of the specialty chemicals company’s stock worth $5,939,000 after buying an additional 9,717 shares during the last quarter. Institutional investors and hedge funds own 93.82% of the company’s stock.
About Innophos Holdings
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.